NIP
CELG

Nicholas Investment Partners’s Celgene Corp CELG Stock Holding History

Nicholas Investment Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,367
Closed -$1.71M – 376
2016
Q3 		$1.71M Buy
+16,367
New +$1.77M 0.11% 268
2016
Q1 		– Sell
-14,749
Closed -$1.77M – 364
2015
Q4 		$1.77M Buy
14,749
+3,157
+27% +$365K 0.12% 262
2015
Q3 		$1.25M Buy
+11,592
New +$1.44M 0.09% 275

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nicholas Investment Partners's CELG Position: Q4 2016 in Review

Nicholas Investment Partners sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 16,367 shares — an estimated $1.71M sold.

Nicholas Investment Partners first reported a position in CELG in Q3 2015 and held it in 3 quarters. The position peaked at $1.77M in Q4 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Nicholas Investment Partners reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Nicholas Investment Partners sold 16,367 Celgene Corp shares in Q4 2016, an estimated $1.71M.
  • Nicholas Investment Partners first reported a position in Celgene Corp in Q3 2015 and held it in 3 quarters.
  • Nicholas Investment Partners's Celgene Corp position peaked at $1.77M in Q4 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Nicholas Investment Partners's 13F filing for Q4 2016, filed 10 Feb 2017.